Assessment of Some Immunological Parameters Postvaccination with Different Types of COVID-19 Vaccines

Background: Coronavirus disease 2019 (COVID-19) is a highly contagious viral infection that can spread rapidly worldwide. Several vaccines have been developed to combat COVID-19. Objectives: This study aimed to assess some immunological parameters, including CD8+ and IgG levels in sera of different...

Full description

Saved in:
Bibliographic Details
Main Authors: Haneen Saad Khasbak, Hayder Shkhair Al-Janabi, Mohanad Jawad Kadhim
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-04-01
Series:Medical Journal of Babylon
Subjects:
Online Access:https://doi.org/10.4103/MJBL.MJBL_1178_23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839630948974460928
author Haneen Saad Khasbak
Hayder Shkhair Al-Janabi
Mohanad Jawad Kadhim
author_facet Haneen Saad Khasbak
Hayder Shkhair Al-Janabi
Mohanad Jawad Kadhim
author_sort Haneen Saad Khasbak
collection DOAJ
description Background: Coronavirus disease 2019 (COVID-19) is a highly contagious viral infection that can spread rapidly worldwide. Several vaccines have been developed to combat COVID-19. Objectives: This study aimed to assess some immunological parameters, including CD8+ and IgG levels in sera of different vaccinated groups with different types of COVID-19 vaccines. Materials and Methods: The current study included 75 samples from vaccinated persons with AstraZeneca, Sinopharm, and Pfizer vaccines and 25 unvaccinated (naturally infected) persons. CD8+ and IgG levels were measured using ELISA technique. Results: The results showed that the CD8+ level increased significantly (P < 0.05) in the Pfizer vaccinated group than in Sinopharm and AstraZeneca groups, and there were no significant differences in the CD8⁺ level in the Pfizer-vaccinated group and unvaccinated group. The results also showed significant differences between CD8+ levels in males (22.78 ± 3.36) and females (9.86 ± 1.16) in Sinopharm vaccine, whereas there were no significant differences in CD8+ levels between males and females in other vaccine groups. COVID-19 IgG antibody levels were elevated significantly in unvaccinated people compared to those who received the Pfizer vaccine. In contrast, there were no significant differences in concentration of IgG antibodies between Sinopharm, AstraZeneca vaccines, and unvaccinated groups. Notably, the Pfizer vaccine exhibited significantly lower IgG levels in all age groups compared to the other vaccines. Conclusion: The Pfizer vaccine induced a cellular immune response represented by CD8+ levels than other COVID-19 vaccines and unvaccinated (naturally infected) people, while natural immunization had higher IgG by inducing a humoral immune response than COVID-19 vaccines.
format Article
id doaj-art-bf2b64a8b1be4e4fb63dc255a9af76a1
institution Matheson Library
issn 1812-156X
2312-6760
language English
publishDate 2025-04-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Medical Journal of Babylon
spelling doaj-art-bf2b64a8b1be4e4fb63dc255a9af76a12025-07-12T15:08:26ZengWolters Kluwer Medknow PublicationsMedical Journal of Babylon1812-156X2312-67602025-04-0122241842510.4103/MJBL.MJBL_1178_23Assessment of Some Immunological Parameters Postvaccination with Different Types of COVID-19 VaccinesHaneen Saad KhasbakHayder Shkhair Al-JanabiMohanad Jawad KadhimBackground: Coronavirus disease 2019 (COVID-19) is a highly contagious viral infection that can spread rapidly worldwide. Several vaccines have been developed to combat COVID-19. Objectives: This study aimed to assess some immunological parameters, including CD8+ and IgG levels in sera of different vaccinated groups with different types of COVID-19 vaccines. Materials and Methods: The current study included 75 samples from vaccinated persons with AstraZeneca, Sinopharm, and Pfizer vaccines and 25 unvaccinated (naturally infected) persons. CD8+ and IgG levels were measured using ELISA technique. Results: The results showed that the CD8+ level increased significantly (P < 0.05) in the Pfizer vaccinated group than in Sinopharm and AstraZeneca groups, and there were no significant differences in the CD8⁺ level in the Pfizer-vaccinated group and unvaccinated group. The results also showed significant differences between CD8+ levels in males (22.78 ± 3.36) and females (9.86 ± 1.16) in Sinopharm vaccine, whereas there were no significant differences in CD8+ levels between males and females in other vaccine groups. COVID-19 IgG antibody levels were elevated significantly in unvaccinated people compared to those who received the Pfizer vaccine. In contrast, there were no significant differences in concentration of IgG antibodies between Sinopharm, AstraZeneca vaccines, and unvaccinated groups. Notably, the Pfizer vaccine exhibited significantly lower IgG levels in all age groups compared to the other vaccines. Conclusion: The Pfizer vaccine induced a cellular immune response represented by CD8+ levels than other COVID-19 vaccines and unvaccinated (naturally infected) people, while natural immunization had higher IgG by inducing a humoral immune response than COVID-19 vaccines.https://doi.org/10.4103/MJBL.MJBL_1178_23astrazenecacd8+covid-19iggpfizersinopharm
spellingShingle Haneen Saad Khasbak
Hayder Shkhair Al-Janabi
Mohanad Jawad Kadhim
Assessment of Some Immunological Parameters Postvaccination with Different Types of COVID-19 Vaccines
Medical Journal of Babylon
astrazeneca
cd8+
covid-19
igg
pfizer
sinopharm
title Assessment of Some Immunological Parameters Postvaccination with Different Types of COVID-19 Vaccines
title_full Assessment of Some Immunological Parameters Postvaccination with Different Types of COVID-19 Vaccines
title_fullStr Assessment of Some Immunological Parameters Postvaccination with Different Types of COVID-19 Vaccines
title_full_unstemmed Assessment of Some Immunological Parameters Postvaccination with Different Types of COVID-19 Vaccines
title_short Assessment of Some Immunological Parameters Postvaccination with Different Types of COVID-19 Vaccines
title_sort assessment of some immunological parameters postvaccination with different types of covid 19 vaccines
topic astrazeneca
cd8+
covid-19
igg
pfizer
sinopharm
url https://doi.org/10.4103/MJBL.MJBL_1178_23
work_keys_str_mv AT haneensaadkhasbak assessmentofsomeimmunologicalparameterspostvaccinationwithdifferenttypesofcovid19vaccines
AT haydershkhairaljanabi assessmentofsomeimmunologicalparameterspostvaccinationwithdifferenttypesofcovid19vaccines
AT mohanadjawadkadhim assessmentofsomeimmunologicalparameterspostvaccinationwithdifferenttypesofcovid19vaccines